OrthoPediatrics Corp (STU:2X7)
€ 22.4 1.2 (5.66%) Market Cap: 531.86 Mil Enterprise Value: 528.61 Mil PE Ratio: 0 PB Ratio: 1.49 GF Score: 70/100

OrthoPediatrics Corp at JMP Securities Life Sciences Virtual Conference Transcript

Jun 17, 2021 / 04:00PM GMT
Dave Turkaly
JMP Securities LLC - Analyst

Great. Thanks, everyone, for joining us today. Next up on the medtech slate, we have OrthoPediatrics. We have Dave Bailey, who is the new CEO; and Fred Hite, who is CFO. We may get Mark later, but let's jump in right now. So Dave, obviously, you have been with the Company a long time but very recently transitioned to CEO. I'd love to just get your thoughts on -- I don't think there is any big strategic changes in the offering here, but sort of where the Company is today and what you could do as the leader moving forward over the next three to five years.

Dave Bailey
OrthoPediatrics Corp. - President & CEO

Great. Thanks, Dave, and it's good to see you. So you are correct; nothing drastically different here. I've been with the Company for almost 15 years, and had the opportunity, really, to work with Mark as my mentor for the last 10 and Fred as a mentor of mine for the last 6. And together, Mark and Fred and I have worked with the executive team to execute a strategy that has been producing really great outcomes

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot